Cancer-associated cachexia

Baracos, Vickie E., Martin, Lisa, Korc, Murray, Guttridge, Denis C., Fearon, Kenneth C. H.·2018·Nature Reviews Disease Primers

Cites (339)

Items 201–339 of 339

  1. Effects of Testosterone Replacement and/or Resistance Exercise on the Composition of Megestrol Acetate Stimulated Weight Gain in Elderly Men: A Randomized Controlled Trial
    Charles Paul Lambert, Dennis H. Sullivan, Scott A. Freeling, Diana M. Lindquist, William J. Evans · 2002 · The Journal of Clinical Endocrinology & Metabolism
  2. Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia
    Cornelis H.C. Dejong, Sylvia Busquets, Alastair G.W. Moses, Patrick Schrauwen, Jim A Ross, Josep María Adell Argilés, Kenneth C. H. Fearon · 2005 · Oncology Reports
  3. Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
    Jwan Khal, S. Wyke, S. Russell, Anna V. Hine, M. J. Tisdale · 2005 · British Journal of Cancer
  4. Cachexia and Brown Fat: A Burning Issue in Cancer
    Serkan Kır, Bruce M. Spiegelman · 2016 · Trends in cancer
  5. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer
    Yosuke Togashi, Akihiro Kogita, Hiroki Sakamoto, Hidetoshi Hayashi, Masato Terashima, Marco Antonio De Velasco, Kazuko Sakai, Yoshihiko Fujita, Shuta Tomida, Masayuki Kitano et al. · 2014 · Cancer Letters
  6. Serum Levels of Transforming Growth Factor β1 in Patients With Breast Cancer
    Shyr‐Ming Sheen‐Chen · 2001 · Archives of Surgery
  7. Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia
    Justin L. Chen, Kelly L. Walton, Hongwei Qian, Timothy D. Colgan, Adam Hagg, Matthew J. Watt, Craig A. Harrison, Paul Gregorevic · 2016 · Cancer Research
  8. An Interprofessional Palliative Care Oncology Rehabilitation Program: Effects on Function and Predictors of Program Completion
    Martin Robert Chasen, Andrea Feldstain, Debbie Gravelle, Neil Macdonald, José Luis Pereira · 2013 · Current Oncology
  9. Nutritional care of cancer patients: a survey on patients’ needs and medical care in reality
    J. Maschke, U. Kruk, Karin Kastrati, Juergen Kleeberg, D. Buchholz, Nicole Tonya Erickson, Jutta Hübner · 2016 · International Journal of Clinical Oncology
  10. Flux of amino acids across the leg in weight-losing cancer patients.
    K. Bennegård, Lars Lindmark, Elisabeth Edén · 1984 · PubMed
  11. Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia
    Douglas E. Friesen, Vickie Elaine Baracos, Jack A. Tuszyński · 2015 · Theoretical Biology and Medical Modelling
  12. C‐reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care
    Koji Amano, Isseki Maeda, Tatsuya Morita et al. · 2017 · Journal of Cachexia Sarcopenia and Muscle
  13. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
    Ola Magne Vagnildhaug, David Blum, Andrew Wilcock, Peter M. Fayers, Florian Strasser, Vickie Elaine Baracos, Marianne Jensen Hjermstad, Stein Kaasa, Barry J. A. Laird, Tora S. Solheim et al. · 2017 · Journal of Cachexia Sarcopenia and Muscle
  14. Which screening method is appropriate for older cancer patients at risk for malnutrition?
    Elisabeth A. Isenring, Marinos Elia · 2015 · Nutrition
  15. Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition
    Federico Bozzetti, Paolo Cotogni, Salvatore Lo Vullo · 2015 · Annals of Oncology
  16. Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia
    Thomas L. Schmitt, Marcus E. Martignoni, Jeannine Bachmann, Kerstin Fechtner, Helmut Friess, Ralf Kinscherf, Wulf Hildebrandt · 2007 · Journal of Molecular Medicine
  17. Structural Analysis of a Tumor-produced Sulfated Glycoprotein Capable of Initiating Muscle Protein Degradation
    Penio T. TODOROV, M.M. Deacon, Michael John Tisdale · 1997 · Journal of Biological Chemistry
  18. Pathophysiology of peripheral muscle wasting in cardiac cachexia
    Gerasimos S Filippatos, Stefan D. Anker, Dimitrios Th. Kremastinos · 2005 · Current Opinion in Clinical Nutrition & Metabolic Care
  19. Family Beliefs Regarding the Nutritional Care of a Terminally Ill Relative: A Qualitative Study
    Susan McClement, Lesley Faith Degner, Michael Harlos · 2003 · Journal of Palliative Medicine
  20. Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice
    Yuichiro Ohe, Eckhard R. Podack, K J Olsen, Y Miyahara, Koh Miura, Hitoshi Saitô, Yasuo Koishihara, Y Ohsugi, Tetsuya Ohira, Kazuto Nishio et al. · 1993 · British Journal of Cancer
  21. Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats.
    A. B. Strelkov, A. Fields, V. Baracos · 1989 · American Journal of Physiology
  22. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats
    L. Combaret, C. Rallière, D. Taillandier, Keiji Tanaka, D. Attaix · 1999 · Molecular Biology Reports
  23. Fat loss in cachexia—is there a role for adipocyte lipolysis?
    Mikael Rydén, Peter Arner · 2006 · Clinical Nutrition
  24. Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer
    Gisela Keller, Volker Grimm, H. Vogelsang, Petra Bischoff, James Mueller, Jörg Rüdiger Siewert, Heinz Höfler · 1996 · International Journal of Cancer
  25. Shifting to conscious control: psychosocial and dietary management of anorexia by patients with advanced cancer
    Jeremy E Shragge, Wendy Victoria Wismer, Karin L. Olson · 2007 · Palliative Medicine
  26. Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance
    Charles H. Lang, Ly Q. Hong‐Brown, Robert A. Frost · 2004 · Pediatric Nephrology
  27. A systematic review of health-related quality of life instruments in patients with cancer cachexia
    Sally J Wheelwright, Anne‐Sophie Darlington, Jane B. Hopkinson, Deborah F. Fitzsimmons, Alice White, Colin D. Johnson · 2013 · Supportive Care in Cancer
  28. Aging, physical activity and height-normalized body composition parameters
    Kyle, Ursula G, Genton, Laurence, Gremion, Gérald, Slosman, Daniel O, Pichard, Claude · 2004 · Clinical Nutrition
  29. Incorporating Biomarkers Into Cancer and Aging Research
    Joleen Marie Hubbard, Harvey Jay Cohen, Hyman Bernard Muss · 2014 · Journal of Clinical Oncology
  30. Clinical predictors of survival in advanced cancer.
    Paul A. Glare · 2005 · PubMed
  31. Habitual Myofibrillar Protein Synthesis Is Normal in Patients with Upper GI Cancer Cachexia
    Alisdair J. MacDonald, Neil Johns, Nathan A. Stephens, Carolyn Anne Greig, James A. Ross, Alexandra C. Small, Holger Husi, Kenneth C.H. Fearon, Tom Preston · 2014 · Clinical Cancer Research
  32. Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist
    S. Kazemi-Bajestani, H. Becher, K. Fassbender, Q. Chu, V. Baracos · 2014 · Journal of Cachexia, Sarcopenia and Muscle
  33. Dietary protein intake impacts human skeletal muscle protein fractional synthetic rates after endurance exercise
    Douglas R. Bolster, Matthew A. Pikosky, P. Courtney Gaine, William F. Martin, Robert R. Wolfe, Kevin D. Tipton, David Maclean, Carl M. Maresh, Nancy R. Rodriguez · 2005 · American Journal of Physiology-Endocrinology and Metabolism
  34. Efficacy of Haloperidol in the Treatment of Nausea and Vomiting in the Palliative Patient
    Patrick P. Critchley, Nadia Plach, Monica Grantham, Denise Marshall, Alan Taniguchi, Bms, Elizabeth J. Latimer, Alejandro R. Jadad · 2001 · Journal of Pain and Symptom Management
  35. Role of prostaglandins in the production of hypercalcemia by tumors.
    Armen H. Tashjian · 1978 · PubMed
  36. A Prospective Evaluation of an Interdisciplinary Nutrition–Rehabilitation Program for Patients with Advanced Cancer
    Bruno Gagnon, Jessica Murphy, Margaret Eades, Josée Lemoignan, Marta Jelowicki, Siobhan Carney, Senda Amdouni, Pasqualina Di Dio, Martin Robert Chasen, Neil Macdonald · 2013 · Current Oncology
  37. Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients
    Nathan A. Stephens, Richard J. E. Skipworth, Iain J. Gallagher, Carolyn Anne Greig, Denis C. Guttridge D, James A. Ross, Kenneth C. H. Fearon · 2015 · Journal of Cachexia Sarcopenia and Muscle
  38. Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001)
    Patrick Bachmann, C Marti-Massoud, M P Blanc-Vincent et al. · 2003 · British Journal of Cancer
  39. The Cachexia Clinic: From Staging to Managing Nutritional and Functional Problems in Advanced Cancer Patients
    Antonio Angelo Luciano Vigano, Egidio Del Fabbro, Eduardo D Bruera · 2012 · Critical Reviews™ in Oncogenesis
  40. Palliation of nausea and vomiting
    Kathryn A. Mannix · 2009 · British Journal of Hospital Medicine
  41. Is α-ketoisocaproyl-glutamine a suitable glutamine precursor to sustain fibroblast growth?
    Colette Coudray‐Lucas, Elisabeth Lasnier, A. Renaud, Frédéric Ziegler, P. Settembre, Luc Cynober, Ovhanesse G. Ekindjian · 1999 · Clinical Nutrition
  42. A leucine-supplemented diet improved protein content of skeletal muscle in young tumor-bearing rats
    Maria Cristina Cintra Gomes‐Marcondes, Gislaine Ventrucci, Mércia Tancredo Toledo, L. Cury, Joanne C. Cooper · 2003 · Brazilian Journal of Medical and Biological Research
  43. n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia
    Vickie Elaine Baracos, Vera Christine Mazurak, David W.L. · 2004 · Nutrition Research Reviews
  44. Arcuate Nucleus Proopiomelanocortin Neurons Mediate the Acute Anorectic Actions of Leukemia Inhibitory Factor via gp130
    Aaron J. Grossberg, Jarrad M. Scarlett, Xinxia Zhu, Darren D. Bowe, Ayesha K. Batra, Theodore P. Braun, Daniel L. Marks · 2009 · Endocrinology
  45. The Science of Megestrol Acetate Delivery
    Robert A. Femia, Richert E. Goyette · 2005 · BioDrugs
  46. Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: the effect of physical activity and oral nutritional supplementation
    Annelies H. C. Goris, Marja A. P. Vermeeren, Emiel F.�M. Wouters, Annemie M.W.J. Schols, Klaas R. Westerterp · 2003 · British Journal Of Nutrition
  47. New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
    Neil Johns, Cynthia Stretch, Benjamin H. L. Tan, Tora S. Solheim, Sveinung Sørhaug, Nathan A. Stephens, Ioannis Gioulbasanis, Richard J.E. Skipworth, D A C Deans, Antonio Angelo Luciano Vigano et al. · 2016 · Journal of Cachexia Sarcopenia and Muscle
  48. Influence of food odors on food aversions and preferences in patients with cancer
    S S Nielsen, Athanasios Theologides, ZATA M. VICKERS · 1980 · American Journal of Clinical Nutrition
  49. Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients
    David P.J. van Dijk, Marcel C.G. van de Poll, Alastair G.W. Moses, Thomas Preston, Steven W.M. Olde Damink, Sander S. Rensen, Nicolaas E.P. Deutz, Peter B. Soeters, James A. Ross, Kenneth C.H. Fearon et al. · 2015 · Journal of Cachexia Sarcopenia and Muscle
  50. Cancer Cachexia and Tumor Growth Reduction in Walker 256 Tumor-Bearing Rats Supplemented With N-3 Polyunsaturated Fatty Acids for One Generation
    Valéria Giglio Togni, Claudia C. C. Ota, Alessandra Folador et al. · 2003 · Nutrition and Cancer
  51. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic
    Rony Dev, David Hui, Gary B. Chisholm · 2015 · Journal of Cachexia Sarcopenia and Muscle
  52. Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer
    Bjørg Sjøblom, Jūratė Šaltytė Benth, Bjørn Henning Grønberg, Vickie Elaine Baracos, Michael B. Sawyer, Øystein Fløtten, Marianne Jensen Hjermstad, Nina Aass, Marit Jordhøy · 2016 · Clinical Lung Cancer
  53. Palatability, food intake and the behavioural satiety sequence in male rats
    Y Ishii, John Edward Blundell, Jason C. G. Halford, R. John Rodgers · 2003 · Physiology & Behavior
  54. Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: a pilot study
    Holger Alexander Ebhardt, Simone Degen, Valentina Tadini, Alain Schilb, Neil Johns, Carolyn Anne Greig, Kenneth C.H. Fearon, Ruedi H. Aebersold, Carsten Jacobi · 2017 · Journal of Cachexia Sarcopenia and Muscle
  55. What is the role of the insulin‐like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?
    Anna L. Crown, Kenneth E. Cottle, Stafford Louis Lightman, Stephen J. Falk, Vidya Mohamed‐Ali, L Armstrong, Ann Millar, Jeff M.P. Holly · 2002 · Clinical Endocrinology
  56. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia
    Didier Attaix, Lydie Combaret, T. Tilignac, Daniel Taillandier · 1999 · Molecular Biology Reports
  57. Gastrointestinal symptoms among inpatients with advanced cancer
    Şeref Kömürcü, Kristine A. Nelson, Declan Walsh · 2002 · American Journal of Hospice and Palliative Medicine®
  58. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?
    Aminah Jatoi, Benedict D.T. Daly, VIRGINIA A. HUGHES, Gerard E. Dallal, Joseph J. Kehayias, Ronenn Roubenoff · 2001 · The Annals of Thoracic Surgery
  59. Prognostic Role of Interleukin-1β Gene and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients With Advanced Gastric Cancer
    Francesco Graziano, Annamaria Ruzzo, Daniele Santini, Bostjan Humar, Giuseppe Tonini, Vincenzo Catalano, Rossana Berardi, Francesca Pizzagalli, Federica Arduini, Italo Bearzi et al. · 2005 · Journal of Clinical Oncology
  60. Alteration of somatotropic function by proinflammatory cytokines.
    R A Frost, Charles H. Lang · 2004 · PubMed
  61. Food connections: A qualitative exploratory study of weight- and eating-related distress in families affected by advanced cancer
    Jane B. Hopkinson · 2015 · European Journal of Oncology Nursing
  62. The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia
    Robert Dallmann, Philipp Weyermann, Corinne Anklin, M. Boroff, Katharine Bray‐French, Bettina Cardel, I. Courdier-Fruh, H. Deppe, Judith Dubach‐Powell, M. Erb et al. · 2011 · Journal of Cachexia Sarcopenia and Muscle
  63. Practical multimodal care for cancer cachexia
    Matthew M Maddocks, Jane B. Hopkinson, John Conibear, Annie Reeves, Clare Shaw, Ken Fearon · 2016 · Current Opinion in Supportive and Palliative Care
  64. Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease
    R. Broekhuizen, Eva C. Creutzberg, Clarie A Weling-Scheepers, Emiel F.�M. Wouters, Annemie M.W.J. Schols · 2005 · British Journal Of Nutrition
  65. White adipose tissue cells and the progression of cachexia: inflammatory pathways
    Rodrigo Xavier das Neves, José Cesar Rosa Neto, Alex Shimura Yamashita, Emídio Marques de Matos‐Neto, Daniela M.R. Riccardi, Fábio Santos Lira, Miguel Luiz Batista Júnior, Marília Cerqueira Leite Seelaender · 2015 · Journal of Cachexia Sarcopenia and Muscle
  66. Systemic immune dysfunction in pancreatic cancer patients
    Bertram Poch, Errki Lotspeich, Marco Ramadani · 2007 · Langenbeck s Archives of Surgery
  67. Cachexia as major underestimated unmet medical need: Facts and numbers
    Stephan von Haehling, Stefan D. Anker · 2012 · International Journal of Cardiology
  68. A systematic review and thematic synthesis of quality of life in the informal carers of cancer patients with cachexia
    Sally J Wheelwright, Anne‐Sophie Darlington, Jane B. Hopkinson, Deborah F. Fitzsimmons, Colin Johnson · 2015 · Palliative Medicine
  69. Increased serum transforming growth factor-β1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration
    A HUANG, Jill W Gilmour, Nesrina Imami · 2003 · Clinical & Experimental Immunology
  70. Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review
    Rosanna Tarricone, Giada Ricca, B. Nyanzi Wakholi, Antonieta Medina‐Lara · 2015 · Critical Reviews in Oncology/Hematology
  71. Characterization of a Human Homologue of Proteolysis-Inducing Factor and Its Role in Cancer Cachexia
    Constance L. Monitto, Seung-Myung Dong, Jin Jen, David Sidransky · 2004 · Clinical Cancer Research
  72. Suppression of cancer cachexia by 20S,21-epoxy-resibufogenin-3-acetate-a novel nonpeptide IL-6 receptor antagonist.
    A. Enomoto, M. Rho, Akiko Fukami, O. Hiraku, K. Komiyama, M. Hayashi · 2004 · Biochemical and Biophysical Research Communications - BBRC
  73. Identification of PTHrP(12-48) as a Plasma Biomarker Associated with Breast Cancer Bone Metastasis
    Charity L. Washam, Stephanie D. Byrum, Kim Leitzel, Suhail M. Ali, Alan J. Tackett, Dana Gaddy, Suzanne E. Sundermann, Allan Lipton, Larry J. Suva · 2013 · Cancer Epidemiology Biomarkers & Prevention
  74. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia
    Rulin Sun, Santao Zhang, Wenjun Hu, Xing Qiang Lü, Ning Lou, Yang Zhen-de, Shaoyong Chen, Xiaoping Zhang, Hongmei Yang · 2016 · American Journal of Physiology-Cell Physiology
  75. Signaling mechanism of tumor cell‐induced up‐regulation of E3 ubiquitin ligase UBR2
    Guohua Zhang, Ren‐Kuo Lin, Yong Tae Kwon, Yiping Li · 2013 · The FASEB Journal
  76. P‐selectin genotype is associated with the development of cancer cachexia
    Benjamin H. L. Tan, Torill Fladvad, Theodore P. Braun, Antonio Angelo Luciano Vigano, Florian Strasser, D A C Deans, Richard J. E. Skipworth, Tora S. Solheim, Sambasivarao Damaraju, James A. Ross et al. · 2012 · EMBO Molecular Medicine
  77. Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden
    Namki Hong, H.J. Yoon, Yong‐ho Lee, Hye Ryun Kim, Byung‐Wan Lee, Yumie Rhee, Eun Seok Kang, Bong Soo, Hyun Chul Lee · 2016 · The Journal of Clinical Endocrinology & Metabolism
  78. Is there a role for TPN in terminally ill patients with bowel obstruction?
    Donald R. Duerksen, Ellen Ting, Patti Thomson · 2004 · Nutrition
  79. Elevated serum level and gene polymorphisms of TGF‐β1 in gastric cancer
    Xue Li, Zhichao Yue, Yun‐Yan Zhang · 2008 · Journal of Clinical Laboratory Analysis
  80. Ghrelin and cachexia: Will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?
    Mark Daniel DeBoer · 2011 · Molecular and Cellular Endocrinology
  81. NF-κBp65 and Expression of Its Pro-Inflammatory Target Genes Are Upregulated in the Subcutaneous Adipose Tissue of Cachectic Cancer Patients
    R. Camargo, Daniela Mendes Dos Reis Riccardi, Henrique Quintas Teixeira Ribeiro, L. C. Carnevali, E. M. de Matos-Neto, L. Enjiu, R. Neves, J. D. C. Lima, R. Figuerêdo, P. S. G. de Alcantara et al. · 2015 · Nutrients
  82. Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With Cachexia
    Sally J. Wheelwright, Jane B. Hopkinson, Anne‐Sophie Darlington, Deborah F. Fitzsimmons, Peter M. Fayers, Trude Rakel Balstad, Anne Brédart, Eva B. Hammerlid, Stein Kaasa, Ourania Nicolatou‐Galitis et al. · 2016 · Journal of Pain and Symptom Management
  83. Skeletal muscle anabolism in patients with advanced cancer
    Vickie Elaine Baracos · 2014 · The Lancet Oncology
  84. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes
    Kelly E. Craven, Jesse Gore, Julie L. Wilson, Murray Korc · 2015 · Oncotarget
  85. Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease
    Kristina L. Go, Daniel Delitto, Sarah M. Judge, Michael H. Gerber, Thomas J. George, K.E. Behrns, Steven J. Hughes, Andrew R. Judge, Jose Gilberto Trevino · 2017 · Pancreas
  86. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus
    Michael M. Meguid, Eduardo J.B. Ramos, Alessandro Laviano · 2004 · Peptides
  87. Pedometer-facilitated walking intervention shows promising effectiveness for reducing cancer fatigue: a pilot randomized trial
    Nancy E. Mayo, Carolina Moriello, Susan Combs Scott, Diana Dawes, Mohammad A. Auais, Martin Robert Chasen · 2014 · Clinical Rehabilitation
  88. Surgical management of malignant bowel obstruction
    Robert S. Krouse · 2004 · Surgical Oncology Clinics of North America
  89. Effects of omega-3 fatty acid supplementation on tumor-bearing rats
    Eduardo J.B. Ramos, Frank A. Middleton, Alessandro Laviano, Tomoi Sato, Irina V. Romanova, Undurti Narasimha Das, Chung Chen, Yong Qi, Michael M. Meguid · 2004 · Journal of the American College of Surgeons
  90. Computational modeling of cancer cachexia
    Kevin D. Hall, Vickie Elaine Baracos · 2008 · Current Opinion in Clinical Nutrition & Metabolic Care
  91. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia
    François Marchildon, Émilie Lamarche, Neena Lala-Tabbert, Catherine St‐Louis, Nadine Wiper‐Bergeron · 2015 · PLoS ONE
  92. Effect of cancer cachexia on triacylglycerol/fatty acid substrate cycling in white adipose tissue
    SA Beck, Michael John Tisdale · 2004 · Lipids
  93. Clinical parameters related to anorexia.
    DeWys Wd, G Costa, R.I. Henkin · 1981 · PubMed
  94. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
    Aminah Jatoi, Karl C. Podratz, P S Gill · 2006 · PubMed
  95. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non‐metastasizing malignancy
    DH Jho, TA Babcock, Rahul Tevar · 2002 · Journal of Parenteral and Enteral Nutrition
  96. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction
    Shuichi Sato, Yuji Ogura, Marjan M. Tajrishi, Ashok Kumar · 2014 · The FASEB Journal
  97. Effects of omega-3 fatty acids on orexigenic and anorexigenic modulators at the onset of anorexia
    Eduardo J.B. Ramos, Irina V. Romanova, Susumu Suzuki, Chung Chen, Michael V. Ugrumov, Tomoi Sato, Carolina Gomes Gonçalves, Michael M. Meguid · 2005 · Brain Research
  98. Diagnostic criteria for cancer cachexia
    Lisa Martin · 2016 · Current Opinion in Clinical Nutrition & Metabolic Care
  99. Patients with established cancer cachexia lack the motivation and self‐efficacy to undertake regular structured exercise
    David Wasley, Nichola Gale, Sioned Roberts, Karianne Backx, Annmarie Nelson, Robert William Martin Van Deursen, Anthony Byrne · 2017 · Psycho-Oncology
  100. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model
    W. Wang, Britt‐Marie Iresjö, Linnéa Karlsson · 2000 · Clinical Nutrition
  101. A mixed-methods qualitative research study to develop a complex intervention for weight loss and anorexia in advanced cancer: The Family Approach to Weight and Eating
    Jane B. Hopkinson, Alison Mead Richardson · 2014 · Palliative Medicine
  102. Health care professionals’ experience, understanding and perception of need of advanced cancer patients with cachexia and their families: The benefits of a dedicated clinic
    David A. Scott, Joanne Reid, Peter Hudson · 2016 · BMC Palliative Care
  103. Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies
    Neil Johns, Benjamin H. L. Tan, Mark T. Macmillan, Tora S. Solheim, J. A. Fergus Ross, Vickie Elaine Baracos, Sambasivarao Damaraju, K. C. H. Fearon · 2014 · Journal of Genetics
  104. Pharmacodynamics of drug-induced weight gain
    S. K. Kulkarni, Gurpreet Kaur · 2001 · Drugs of today
  105. Parenteral Nutrition in Advanced Cancer: Indications and Clinical Practice Guidelines
    Noush Mirhosseini, Robin L. Fainsinger, Vickie Elaine Baracos · 2005 · Journal of Palliative Medicine
  106. Omics/systems biology and cancer cachexia
    Iain J. Gallagher, Carsten Jacobi, Nicolas Tardif, Olav Rooyackers, Kenneth Fearon · 2016 · Seminars in Cell and Developmental Biology
  107. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response
    Dunwei Guo, Chaoyi Wang, Qiang Wang, Zhongpeng Qiao, Hua Tang · 2017 · Oncotarget
  108. Amplification of the parathyroid hormone-related peptide gene in a colonic carcinoma.
    B. Sidler, Laurence I. Alpert, Janet E. Henderson · 1996 · The Journal of Clinical Endocrinology & Metabolism
  109. Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor‐bearing mice
    Andrew Hitt, Erin Graves, Donna O. McCarthy · 2004 · Research in Nursing & Health
  110. Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon‐26 adenocarcinoma
    Donna O. McCarthy, Pamela Whitney, Andrew Hitt, Sadeeka Al‐Majid · 2004 · Research in Nursing & Health
  111. Clinical undernutrition states and their influence on taste
    H. I. M. Davidson, R. M. Pattison, Rosemary Richardson · 1998 · Proceedings of The Nutrition Society
  112. Changes in hypothalamic neuropeptide Y and monoaminergic system in tumor-bearing rats: Pre- and post-tumor resection and at death
    Eduardo J.B. Ramos, Susumu Suzuki, Michael M. Meguid · 2004 · Surgery
  113. Normalization of hypothalamic serotonin (5-HT1B) receptor and NPY in cancer anorexia after tumor resection: An immunocytochemical study
    Irina G. Makarenko, Michael M. Meguid, Louis A. Gatto · 2005 · Neuroscience Letters
  114. Pancreaticoduodenectomy: ERAS recommendations
    Kristoffer Lassen, Olle H. Ljungqvist, C.H.C. Dejong · 2013 · Clinical Nutrition
  115. Feeding response to change in absorbable food fraction during growth of Walker 256 carcinosarcoma.
    S. D. Morrison · 1972 · PubMed
  116. Growth hormone releasing hormone plasmid supplementation, a potential treatment for cancer cachexia, does not increase tumor growth in nude mice
    Amir Sada Khan, Louis C. Smith, Ingrid W Anscombe, Kathleen K. Cummings, Melissa A Pope, Ruxandra Draghia · 2004 · Cancer Gene Therapy
  117. Omega-3 fatty acids and anorexia
    Carolina Gomes Gonçalves, Eduardo JB Ramos, Susumu Suzuki, Michael M. Meguid · 2005 · Current Opinion in Clinical Nutrition & Metabolic Care
  118. Book Review The Camel's Nose: Memoirs of a curious scientist By Knut Schmidt-Nielsen. 339 pp., illustrated. Washington, D.C., Island Press, 1998. $24.95. 1-55963-512-6
    Franklin H. Epstein · 1999 · New England Journal of Medicine
  119. Presence of early stage cancer does not impair the early protein metabolic response to major surgery
    MARIËLLE P. K. J. ENGELEN, Vicki Suzanne Klimberg, Arianna Allasia · 2017 · Journal of Cachexia Sarcopenia and Muscle
  120. Change of the growth hormone–insulin-like growth factor-I axis in patients with gastrointestinal cancer: related to tumour type and nutritional status
    Qi Huang, Yong-Jun Nai, Zhiwei Jiang · 2005 · British Journal Of Nutrition
  121. ESPEN guideline on ethical aspects of artificial nutrition and hydration
    Federico Bozzetti · 2016 · Clinical Nutrition
  122. Omics and cachexia
    Brigitte Twelkmeyer, Nicolas Tardif, Olav Rooyackers · 2017 · Current Opinion in Clinical Nutrition & Metabolic Care
  123. Ghrelin and cachexia
    Akio Inui, M. M. Meguid · 2002 · Diabetes Obesity and Metabolism
  124. Insight into the growth hormone–insulin-like growth factor-I axis in cancer cachexia
    Chen Bing · 2005 · British Journal Of Nutrition
  125. Efficacy of Enteral and Parenteral Nutrition in Cancer Patients
    Federico Bozzetti, Valentina Bozzetti · 2005 · KARGER eBooks
  126. RELATIONSHIP BETWEEN BODY COMPOSITION AND CYTOKINES IN CACHECTIC PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Shing‐Shing Yeh, Alice Hafner, Michael W. Schuster · 2003 · Journal of the American Geriatrics Society
  127. Animal Models for Nutrition in Cancer
    Vickie Elaine Baracos, Thierry Le Bricon · 2000 · KARGER eBooks
  128. A Prospective Study of Gastric Emptying and Its Relationship to the Development of Nausea, Vomiting, and Anorexia after Autologous Stem Cell Transplantation
    John K. DiBaise, ELIZABETH R. LYDEN, Stefano Tarantolo · 2005 · The American Journal of Gastroenterology
  129. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice.
    Sanda Šturlan, Britta G. Beinhauer, Georg Oberhuber, Leaf Huang, Ansgar Oddne Aasen, Michael A. Rogy · 2002 · PubMed
  130. Protein turnover states of tumour cells and host tissues in an experimental model.
    Franco M. Baccino, Luciana Tessitore, Gabriella Bonelli · 1986 · PubMed
  131. The use of self-expandable metal stents in the palliation of malignant bowel obstruction
    M. Okorie, Syed A. Hussain, Peter L. Riley · 2004 · Oncology Reports
  132. VMN/LHA Functional Inhibition in Tumor-bearing Rats Suggests Hypothalamic Involvement in Cancer Anorexia
    Alessandro Laviano, M. M. Meguid, John R. Gleason · 2002 · Nutritional Neuroscience
  133. Letter to the editor
    Nabeel Sarhill, Richard Christie · 2002 · American Journal of Hospice and Palliative Medicine®
  134. Cytokines and the Pathophysiology of Skeletal Muscle Atrophy
    Vickie Elaine Baracos · 2005 · CRC Press eBooks
  135. Serotonin and Cancer Anorexia: Myths or Facts?
    Alessandro Laviano, Filippo Rossi Fanelli, M. M. Meguid · 2005 · Journal of Clinical Oncology
  136. Mitogen-Activated Protein Kinases Inhibitors: Potential Therapeutic Agents for Cancer Cachexia
    Vickie Elaine Baracos · 2017 · Molecular Cancer Therapeutics
  137. Comprehensive cancer cachexia staging and its impact in the outpatient oncology setting: A phase II study
    David Blum, J. Hess, Aurelius Gabriel Omlin · 2009 · Journal of Clinical Oncology
  138. Untitled work
    1997 · 10.1002/(sici)1097-0185(199707)248:3
  139. Rapid screening for psychologic distress in men with prostate carcinoma
    Roth, Andrew J., Kornblith, Alice B., Batel-Copel, Laure, Peabody, Elizabeth, Scher, Howard I., Holland, Jimmie C. · 1998 · Cancer